In addition, the mean catalase levels of cancer patients with vitamin D deficiency (196.29 U/mg Hb) were significantly lower (p = 0.030) than the mean catalase marker of non-cancer patients with vitamin D deficiency (218.72 U/mg Hb) (Figure 3). The gene discussed is GSTM1; the disease is vitamin D deficiency.